Cytosorbents Corporation Common Stock (NASDAQ: CTSO) last traded at $0.370, up 18.93% on the session. The quote above updates while this page is open; the figures below are drawn from Cytosorbents Corporation Common Stock’s own filings and are restated only when a new one is published.
Cytosorbents Corporation Common Stock trades on NASDAQ under the ticker CTSO. Its market capitalisation is $23.25 million.
Valuation measures for Cytosorbents Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $23.25M |
|---|---|
| Enterprise value | $57.55M |
| Price / sales | 0.62 |
| Beta | 1.17 |
Trailing-twelve-month figures tagged in Cytosorbents Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $37.22M |
|---|---|
| Net income (TTM) | -$18.21M |
| EPS (TTM) | -$0.290 |
| Gross margin | 71.61% |
| Operating margin | -34.74% |
| Cash | $4.41M |
Range and volume for CTSO over the past 52 weeks.
| 52-week high | $1.04 |
|---|---|
| 52-week low | $0.300 |
| Volume | 325.8K |
| Average volume | 156.0K |
| Previous close | $0.311 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.